A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*

• Main Authors: Vincent JL., Ramesh MK., Ernest D., Larosa SP., Pachl J., Aikawa N., Hoste E., Levy H., Hirman J., Levi M., Daga M., Kutsogiannis DJ., Crowther M., Bernard GR., Devriendt J., Puigserver JV., Blanzaco DU., Esmon CT., Parrillo JE., Guzzi L., Henderson SJ., Pothirat C., Mehta P., Fareed J., Talwar D., Tsuruta K., Gorelick KJ., Osawa Y., Kaul I.
• Format: Article
• Language: English
• Published: 2014
• Online Access: http://www.ncbi.nlm.nih.gov/pubmed/23979365; http://cmuir.cmu.ac.th/handle/6653943832/4188
• Institution: Chiang Mai University

<strong>UNASSIGNED : </strong>To determine the safety and efficacy of recombinant thrombomodulin (ART-123) in patients with suspected sepsis-associated disseminated intravascular coagulation.<br /><strong>UNASSIGNED : </strong>Phase 2b, international, multicenter, doubl...